Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals in the USA. LDCT has resulted in increased detection of stage I lung cancer for which the current standard of care is surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Meaney, Claire L., Zingone, Adriana, Brown, Derek, Yu, Yunkai, Cao, Liang, Ryan, Bríd M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522266/
https://www.ncbi.nlm.nih.gov/pubmed/28402963
http://dx.doi.org/10.18632/oncotarget.16784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522266/
https://www.ncbi.nlm.nih.gov/pubmed/28402963
http://dx.doi.org/10.18632/oncotarget.16784

Ejemplares similares